| Pharmaceutical active ingredients: |
| Asparaginase |
| Available forms, composition and doses of Kidrolase: |
| Injectable; Injection; Asparaginase 10,000 units |
| Kidrolase medical category: |
| Human:Antineoplastic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XX02 - Asparaginase |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisEUSA PharmaOPI Laboratoire |
| Related documents and information about Kidrolase: |
| Kidrolase prescribing information (PDF) |